Die Finanzierung dient der Ausweitung der Produktion von OSCPs ITAR-freien photonischen IMUs in Montreal, da die Nachfrage nach Navigationslösungen steigt, die auch bei gestörtem GNSS-Signal funktionieren.

MONTRÉAL, 1. Oktober 2026 — OSCPS Motion Sensing Inc., firmierend unter dem Namen OSCP, gab heute bekannt, dass es eine Serie-A-Finanzierungsrunde unter der Führung von New Science Ventures und unter Beteiligung von Emerging Ventures sowie 2050 Capital abgeschlossen hat. Somu Subramaniam, Gründer und geschäftsführender Gesellschafter von New Science Ventures, ist dem Vorstand von OSCP beigetreten.

Die photonischen Gyroskope und Inertialsensoren (IMUs) von OSCP sind für Plattformen konzipiert, die auch dann navigationsfähig bleiben müssen, wenn GNSS-Signale gestört oder manipuliert werden oder nicht verfügbar sind – ein Problem, das mittlerweile weit über erklärte Konfliktzonen hinausreicht.

Das Unternehmen wird die Finanzmittel nutzen, um die Produktion in Montréal auszuweiten, seine Entwicklungs- und Vertriebsteams zu vergrößern und seine nächste Generation photonischer Trägheitssensoren auf den Markt zu bringen.

„Der Verlust des Satellitensignals war früher ein Problem auf dem Schlachtfeld. Heute tritt er über Flughäfen und Schifffahrtsrouten auf”, sagte Kazem Zandi, Gründer und Geschäftsführer von OSCP. „Kunden wollen eine Navigation, auf die sie sich verlassen können, wenn GNSS ausfällt, und sie wollen, dass sie ITAR-frei ist. Diese Finanzierungsrunde ermöglicht es uns, hier mehr davon zu bauen – und das schneller.”

„Wir freuen uns sehr darauf, dem Team von OSCP beizutreten, um die weltweit besten IMUs in Bezug auf Navigationsleistung, Größe und Kosten zu entwickeln. Diese IMUs haben das Potenzial, das Paradigma der autonomen Navigation in einer Vielzahl von Anwendungen im Verteidigungs- und Transportsektor grundlegend zu verändern”, sagte Somu Subramaniam, Gründer und geschäftsführender Gesellschafter von New Science Ventures.

Seit Abschluss der Finanzierungsrunde im August hat OSCP „NavigationGate” eingeführt, ein Trägheitsnavigationssystem für Plattformen, die das Satellitensignal verlieren. Außerdem hat das Unternehmen die Unterstützung für ArduPilot sowie einen Open-Source-ROS 2-Treiber für seine MK2 IMU-Produktfamilie hinzugefügt und sich als Lieferant für den „Defence Drone Initiative Marketplace” Kanadas qualifiziert. Weitere Informationen finden Sie unter oscp.com.

INFORMATIONEN ZU OSCP

OSCPS Motion Sensing Inc., firmierend unter dem Namen OSCP, entwickelt und fertigt photonische Gyroskope und Trägheitsmesseinheiten. Das 2015 gegründete Unternehmen mit Sitz in Montréal, Québec, entwickelt Trägheitssensoren, die photonische Genauigkeit auf taktischem Niveau bei Größe, Gewicht, Leistungsaufnahme und Kosten von MEMS bieten – für die Navigation in Situationen, in denen GNSS gestört, beeinträchtigt oder nicht verfügbar ist. Die Kunden des Unternehmens sind in den Bereichen Raumfahrt, Verteidigung, Schifffahrt und Unterwassertechnik, Schienenverkehr, Robotik sowie autonome Bodensysteme tätig. OSCP-Produkte werden in Kanada hergestellt und unterliegen nicht den ITAR-Bestimmungen.

INFORMATIONEN ZU NEW SCIENCE VENTURES

New Science Ventures ist eine Risikokapitalgesellschaft, die in Unternehmen investiert, die neuartige wissenschaftliche Ansätze in den Bereichen Informationstechnologie und Biowissenschaften verfolgen. Das 2004 gegründete Unternehmen mit Niederlassungen in Greenwich, Connecticut, und London verwaltet ein Vermögen von mehr als 1 Milliarde US-Dollar, basierend auf dem ursprünglich zugesagten Kapital. Weitere Informationen finden Sie unter newscienceventures.com.

Pressekontakt: [email protected]

Fund I seeks to invest in early-stage companies developing technology and services for community health centers and the broader healthcare safety net

LOS ANGELES, Oct. 1, 2026 — Facktor Ventures Management, LLC today announced the launch of Facktor Ventures Fund I LP, an early-stage venture capital fund focused on companies serving community health centers and the broader healthcare safety net. Fund I expects to invest primarily at the Seed and Series A stages in digital health, healthcare software, and healthcare services companies addressing the realities of safety-net care. Target areas include clinical and administrative workflows, workforce capacity, patient access and engagement, revenue cycle performance, care management, behavioral health, data and analytics, and cybersecurity.

Facktor Ventures was established in affiliation with Facktor, a national consulting firm focused on Federally Qualified Health Centers and other safety-net healthcare organizations. Since 2006, Facktor has worked directly with more than 360 health centers, while its network clients collectively reach approximately half of all U.S. health centers.

“Community health centers serve nearly 33 million people yet remain underrepresented in healthcare innovation and venture investing,” said Jay Boyer, General Partner of Facktor Ventures and Facktor’s Managing Partner. “We are building on 20 years of relationships and operating experience to help companies understand this market, develop solutions that work within it, and scale alongside the organizations delivering care.”

Facktor Ventures is being built with the health center movement. The fund’s goal is to be majority owned by health centers and other safety-net organizations, enabling those providers to participate in the value created by healthcare innovation and bring their perspectives directly into the investment ecosystem.

“Companies that succeed in the safety net understand its distinct payment models, regulatory requirements, technology environments, workforce constraints, and patient needs,” said Michael Ceballos, Partner at Facktor Ventures and Senior Director at Facktor. “We seek to help founders design for those realities and give health centers a meaningful voice and stake in the solutions that are built, tested, and scaled.”

About Facktor Ventures
Facktor Ventures is an early-stage venture capital firm that seeks to invest in technology and services that strengthen community health centers and the broader healthcare safety net. Built on Facktor’s national relationships, sector expertise, and 20 years of work in community health, the firm seeks to connect founders with capital, insight, partners, and market access.

About Facktor
Founded in 2006, Facktor is a national healthcare consulting firm advancing community-based care. Its multidisciplinary team advises community health centers, health center-controlled networks, primary care associations, clinically integrated networks, and other mission-driven healthcare organizations. Facktor has worked directly with more than 360 health centers, with additional reach through network clients that collectively serve approximately half of all U.S. health centers. Learn more at facktorhealth.com.

FORWARD-LOOKING STATEMENTS
This press release contains statements that constitute “forward-looking statements,” including with respect to the launch of Fund I and the expected investment objective and strategy Fund I expects to pursue. No assurance can be given that the Fund I will be able to successfully attract the needed investors or that it will find suitable target companies for its investment program. Even if such investments are made, there is no guarantee that any such investment will be profitable. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Facktor. Facktor undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Media Contact
Michael Ceballos
Partner, Facktor Ventures
[email protected]
614.404.8804

SOURCE Facktor Ventures

Saluda Grade leads round; Funding to grow Homeward’s proptech financial solutions and platform

AUSTIN, Texas, Oct. 1, 2026 — Homeward, a leader in cash-backed real estate financing solutions, today announced $120 million in equity financing and $330 million in asset-backed debt facilities. The new capital will expand Homeward’s cash offer and bridge financing solutions, enhance the technology powering its integrated home buying and selling platform, and accelerate growth nationwide across the 48 contiguous states.

More than two million licensed real estate professionals guide buyers and sellers through home transactions every year. In today’s market, homes can take longer to sell, making it harder for homeowners to move when they want to and for agents to keep transactions on track. Homeward helps address these challenges with technology-backed financing solutions that remove home-sale contingencies, provide fast access to home equity, and strengthen purchasing power.

“Guidance and expertise from trusted real estate agents will always be at the center of every successful home transaction,” said Tim Heyl, founder and CEO of Homeward. “We’re agents ourselves, so we built Homeward to help fellow agents solve the real problems their clients face every day. This investment allows us to expand our cash offer and bridge financing solutions, helping agents win more business, deliver a better client experience and close more deals.”

Led by Saluda Grade, an alternative investment firm specializing in asset-backed credit, alongside Continental General Insurance Company, Citi Ventures, Magnetar, Harmony Partners, Norwest, Adams Street Partners, LiveOak Ventures, Parker89, Era Ventures, Javelin Venture Partners, and others, the $120 million series D investment builds on Homeward’s differentiated approach to seamless buying and selling. The $330 million asset-backed debt facility will be used to fund more home transactions.

“Homeward is working to solve a financing problem that arises at a consequential moment for homeowners and their agents,” said Ryan Craft, founder and CEO of Saluda Grade. “We believe Tim and his leadership team have extensive experience in this market and have made commendable progress in proving their operating model. We are pleased to support this exceptional team and are enthusiastic about the opportunity this asset class presents.”

Homeward offers a suite of cash offer and bridge financing opportunities:

• Buy Before You Sell gives homeowners the convenience to purchase their next home before selling their current one through short-term bridge financing and a guaranteed backup offer that removes the home sale contingency.
• Cash Offer provides homeowners with the speed and certainty of a cash sale while allowing them to participate in the upside when the home is later resold.
• Buy with Cash enables buyers to make competitive cash-backed offers and then refinance into a traditional mortgage after closing.

“Every transaction presents a different challenge,” said Andrew Franklin, CEO of the Franklin Team at eXp Realty. “We’ve completed dozens of transactions with Homeward because their cash offer and bridge financing solutions give our agents the flexibility to solve problems, keep deals together and ultimately achieve their goals.”

Homeward’s technology platform also brings together Homeward Mortgage and Homeward Title services into an integrated experience for agents and their clients. By connecting every stage of the transaction, Homeward helps streamline the home buying and selling process while giving buyers, sellers and agents greater visibility and confidence from offer through closing.

“In this slow moving market, our clients need to know their existing home will sell in time,” said Chris Marti, CEO of NuMouve at Keller Williams. “Homeward gives us a guaranteed solution, keeping our deals moving. That’s how we win listings and get more referrals.”

Since its founding, Homeward has partnered with more than 25,000 agents and facilitated over four billion dollars in residential real estate transactions.

About Homeward

Homeward helps real estate professionals better serve their clients and grow their business through an integrated suite of home buying, financing, mortgage and title solutions. Homeward helps buyers make more competitive offers, removes common transaction barriers and gives buyers and sellers greater certainty throughout the home buying and selling process. Headquartered in Austin, Texas, Homeward operates in markets across the United States. Learn more at www.homeward.com.

Important Information:

The foregoing statements reflect the experience of certain Homeward business partners. Individual experiences may vary. No compensation was provided for this testimonial. Statements regarding anticipated growth, expansion plans, product benefits, and future business performance are forward-looking statements based on current expectations and assumptions. Actual results may differ materially due to market conditions, regulatory developments, economic factors, and other risks. Homeward’s financing products are subject to eligibility requirements, underwriting criteria, and terms and conditions. References to portfolio investments are provided for illustrative purposes only and should not be assumed to be profitable.

Kelsey Tomascheski, [email protected]

SOURCE Homeward

PITTSBURGH, Oct. 1, 2026 — GENISOM AI, a full-stack embodied AI company developing and manufacturing quadruped robots, humanoid robots and physical AI systems, showcased its latest robotics platforms and embodied intelligence technologies at the 2026 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2026) in Pittsburgh, highlighting its evolution from individual robot intelligence toward coordinated robotic systems built for the real world.

At IROS 2026, GENISOM AI presented its quadruped robot and robot dog platforms, the World’s First Industry-Grade Educational Quadruped for Hands-On Assembly and Development, Genisom L1 Maker, robotic joint modules and its open-source MATRiX 2.0 robotics simulation platform. At the accompanying IROS 2026 Legged Robot Challenges, the Nanyang Technological University team took first place in the fully autonomous category with the company’s GENISOM M1 quadruped robot.

From Individual Intelligence to Swarm Intelligence

GENISOM AI’s embodied intelligence framework integrates Locomotion Intelligence, Spatial Intelligence, Interaction Intelligence and Swarm Intelligence, enabling robots to perceive, understand, move and collaborate in the physical world.

A recent milestone is the company’s Multi-Legged Collaborative Transport system, demonstrating multi-robot collaboration and Swarm Intelligence through coordinated movement and task execution. The system represents GENISOM AI’s move from single-robot intelligence toward collective robotic behavior and multi-robot task execution.

This approach connects perception, locomotion and task coordination across multiple embodied agents, extending physical AI from individual robot capabilities toward coordinated robotic systems.

World’s First Industry-Grade Educational Quadruped

At IROS 2026, GENISOM AI made the international debut of Genisom L1 Maker, the World’s First Industry-Grade Educational Quadruped for Hands-On Assembly and Development.

Built on the mass-produced Genisom L1 platform, L1 Maker gives students, educators, researchers and developers hands-on access to the complete robotics development process—from assembly and system integration to production-level calibration, motion control and algorithm development.

Unlike conventional educational robot kits focused primarily on programming, L1 Maker enables users to build, modify, calibrate and develop on a production-grade quadruped platform, bridging robotics education, research and real-world engineering.

The platform features 12 degrees of freedom, an 8 kg maximum payload, up to 40° slope climbing and open interfaces for additional sensors and computing hardware.

Open-World Simulation for Multi-Robot Intelligence

Supporting this development is MATRiX 2.0, GENISOM AI’s open-source robotics simulation platform designed to support open-world simulation and multi-robot training.

MATRiX 2.0 provides researchers and developers with an environment to develop and test robotic perception, navigation, locomotion and multi-robot collaboration before deployment on physical systems, helping accelerate the development cycle from simulation to real-world robotics.

Together with GENISOM AI’s robot platforms and embodied intelligence systems, MATRiX 2.0 forms part of the company’s technology stack for developing robots that can operate and collaborate in complex physical environments. [Opensource: https://github.com/zsibot/matrix]

GENISOM Robots Support Back-to-Back Championship Wins at the IROS Legged Robot Challenges

University robotics teams have continued to put GENISOM AI’s quadruped robot platforms to the test at the IROS Legged Robot Challenge. In 2025, the University of Manchester team won the competition with the mass-produced GENISOM L1 platform.

At the 2026 IROS Legged Robot Challenge, the Nanyang Technological University team from Singapore selected GENISOM M1 as its quadruped robot platform and claimed the championship. The team developed and integrated its own autonomous robotics system on the platform, enabling GENISOM M1 to independently perceive the competition environment, dynamically plan routes, navigate to target locations and operate a robotic arm to complete assigned tasks without manual remote-control intervention.

The back-to-back championship results highlight how university research teams are using production-grade quadruped robots as platforms for developing and testing autonomous navigation, perception, motion control and robotic manipulation in real-world competition environments.

15,000+ Robots in the Real World

GENISOM AI develops technologies across robotic hardware, high-performance joint modules, embodied intelligence and simulation, with products deployed across industrial inspection, power and utilities, petrochemical facilities, emergency response, security, education and other applications.

As of June 2026, the company had produced more than 15,000 robots and worked with more than 500 ecosystem partners worldwide.

Ahead of IROS 2026, GENISOM AI also completed a Series B financing round worth hundreds of millions of RMB, led by Stone Venture, a UAE-based investment firm. The financing will support continued investment in robot platforms, embodied intelligence and real-world applications as the company expands internationally.

From the World’s First Industry-Grade Educational Quadruped to multi-robot collaboration and open-world simulation, GENISOM AI is continuing to develop embodied intelligence and physical AI systems designed for the real world.

About GENISOM AI

GENISOM AI is a Beijing-based full-stack embodied AI company developing and manufacturing quadruped robots, humanoid robots, robotic joint modules and embodied intelligence technologies.

The company integrates robotics hardware, embodied intelligence software, open-source simulation and manufacturing capabilities to develop robots for real-world applications.

As of June 2026, GENISOM AI had produced more than 15,000 robots and worked with more than 500 ecosystem partners worldwide.

For more information, visit:
Website: https://www.genisomai.com/en/
LinkedIn: https://www.linkedin.com/company/genisom-ai
X: https://x.com/GenisomAI
Instagram: https://www.instagram.com/genisomai/
YouTube: https://www.youtube.com/@GenisomAI 

SOURCE GENISOM AI

Seasoned finance and operations executive brings more than two decades of experience building scalable financial infrastructure, guiding growth, and supporting strategic transactions.

CAMPBELL, Calif., Oct. 1, 2026 — Zircon Corporation, a Silicon Valley-based technology innovator and leader in sensor-based electronic hand tools, today announced the appointment of Angela Sweeney as Chief Financial Officer.

In this role, Sweeney will lead Zircon’s finance organization and shape the company’s financial strategy across planning, reporting, treasury, capital strategy, controls, and systems. Her leadership will further strengthen the financial foundation supporting Zircon’s growth, continued investment in innovation, customer focus, and strategic priorities.

Sweeney joins Zircon with more than 20 years of finance and operational leadership experience across high-growth, manufacturing and technology companies. She brings hands-on manufacturing experience from aerospace, robotics, and medical devices, along with work in SaaS, biotechnology, and fintech. She has helped scale 14 startups and guided 16 mergers and acquisitions.

She has held senior finance and operational positions at Poplar Homes, Astra, Engagor, and Venga Global, and advises founders and executive teams on financial strategy, planning, fundraising, M&A, and scalable operations. Across those roles, she has led multimillion-dollar treasury operations, helped raise more than $100 million in debt and equity capital, strengthened forecasting and reporting functions, and built the financial systems and controls needed to support growth, informed decision-making, and long-term value creation.

“Angela brings a rare combination of financial rigor, strategic perspective, and an operator’s mindset,” said John Stauss, Chief Executive Officer of Zircon Corporation. “She connects financial strategy to the broader business and understands how to build the infrastructure that enables a company to move decisively, invest intelligently, and execute against its priorities. Her leadership will be a strategic asset as Zircon builds on its innovation legacy and pursues its next chapter of growth.”

“I am excited to join Zircon at an important point in its evolution,” said Sweeney. “For more than 50 years, Zircon has earned the trust of professionals and homeowners by building tools that are accurate, dependable, and built to last. I believe finance should work the same way: precise, transparent, and designed for the long term. I look forward to partnering with John, the leadership team, and employees across the company to give Zircon the financial clarity and flexibility to keep investing in innovation and in the customers who rely on its products.”

Sweeney’s appointment adds further depth to Zircon’s leadership team as the company advances its product pipeline, strengthens its operating capabilities, and expands the platform needed to serve customers and partners worldwide.

About Zircon Corporation
Zircon Corporation, a wholly-owned subsidiary of ZRCN Inc., is a global manufacturer and seller of electronic hand tools, including stud finders, metal detectors, electrical scanners, water detectors, and other innovative electronic tools. Zircon has been a technology leader in its field since its inception, leveraging over 80 global patents and registered designs based on sensor and semiconductor-based technologies. In 2025, the company celebrated its 50th anniversary, marking a legacy of industry innovation and a commitment to quality for customers worldwide. To learn more, visit zircon.com.

Media Contact
Jennifer Lim
Chief Marketing Officer
Zircon Corporation
[email protected]

SOURCE Zircon Corporation

Investment positions Curi Capital to build on its momentum as a national independent RIA and trusted wealth management partner.

CHICAGO, Oct. 1, 2026 — Curi Capital, a registered investment adviser (“RIA”) with over $14 billion in assets under advisement¹, today confirmed the completion of its previously announced strategic partnership with The Vistria Group, LP (“Vistria”), a middle market private investment firm with deep expertise across essential industries.

The completed investment marks an important milestone in Curi Capital’s continued evolution as a national RIA, providing additional resources to expand its wealth management and financial planning capabilities while enhancing the client experience. Curi Capital will continue to be led by its existing management team and operate under its current name and service model. Currently, the firm serves high-net-worth individuals, families, healthcare professionals, business owners and institutions and operates from 12 offices across eight states and the District of Columbia.

“This partnership represents an important next chapter for Curi Capital,” said Dimitri Eliopoulos, CEO of Curi Capital. “We have built a strong business around a simple idea: put clients first and build a firm where talented people can do their best work. Vistria shares that philosophy and has been a welcome thought partner for our teams as we turn to the specifics of strengthening and growing the business.”

Curi Capital represents Vistria’s latest investment in financial services, a sector where the firm has developed significant expertise through partnerships across wealth management, retirement services, employee benefits and insurance.

“Curi Capital has the ability to pair sophisticated wealth management and financial planning capabilities with a highly personalized client experience. That combination is difficult to build, and we believe it creates a strong foundation for long-term growth,” said Boris Rapoport, Senior Partner and Co-Head of Financial Services at The Vistria Group.

“We have spent years building our financial services strategy and identifying businesses that we believe can lead their markets. Curi Capital stands out for its leadership, culture and commitment to clients. We are proud to partner with Dimitri and his team and look forward to supporting them in this next chapter,” said Mike Castleforte, Senior Partner and Co-Head of Financial Services at The Vistria Group.

The partnership strengthens Curi Capital’s ability to invest in its people, technology and client experience while pursuing opportunities to expand its capabilities and geographic reach. Wealth Partners Capital Group will continue to play a key role in supporting Curi Capital’s strategic growth and M&A initiatives. Curi Capital remains focused on delivering personalized financial planning, wealth advisory and investment management solutions designed around every client’s goals and circumstances.

“This is ultimately about giving our clients and our people an even stronger platform for the future,” said Eliopoulos. “We are grateful for the trust our clients have placed in us and excited to enter this next phase with the same commitment to them that has guided Curi Capital from the beginning.”

Vistria’s investment is being made alongside Curi Capital’s employee owners and existing shareholders, including Curi and Wealth Partners Capital Group. Curi will remain a significant partner and shareholder of Curi Capital.

Financial terms of the transaction were not disclosed.

About Curi Capital

Curi Capital is a national investment advisory firm that puts clients at the center of its mission: helping individuals, families, and institutions reach their long-term financial goals. Curi Capital’s roots date to 2005, when RMB Capital was founded in Chicago. The organization merged with Curi Capital in 2024.

Today, Curi Capital brings in-house, institutional-quality investment expertise together with experienced, holistic planning teams to deliver and implement personalized planning strategies for each client. Headquartered in Chicago, Curi Capital has 12 offices across eight states and the District of Columbia.

About The Vistria Group

The Vistria Group is building a new kind of private investment firm that seeks to deliver both financial returns and societal impact. It invests in essential industries like healthcare, knowledge & learning solutions, financial services and housing that deliver value for investors as well as communities, employees, and consumers.

With over $18 billion in AUM, The Vistria Group looks deeper by working as a true partner, drawing on its deep sector knowledge, operational expertise, unique network, diverse team, and impact orientation to achieve transformational growth.

About Curi

Curi is a national healthcare advisory firm bringing together specialized expertise across medical professional liability insurance, management consulting, and wealth and investment management. As fierce healthcare advocates, business leaders, and thoughtful partners, Curi provides valued advice and support grounded in a specialized understanding of the complex circumstances facing the clients and communities they serve.

About Wealth Partners Capital Group

Wealth Partners Capital Group (“WPCG”) is a financial services holding company, which invests in and partners with select leading wealth management firms. WPCG’s mission is to use its capital, strategic M&A expertise and organic growth capabilities to help its partner firms grow. WPCG identifies, values and negotiates with wealth advisory practices for its partners to acquire and integrate.

¹ Estimated assets under advisement (“AUA”) as of 6/30/2026. Total AUA presented here differs from regulatory assets under management (“RAUM”) reported on Curi Capital’s Form ADV. AUA reflects net assets under management for private funds, retirement plan services, and mutual funds managed by Curi Capital, while RAUM reflects gross assets under management and excludes retirement plan assets.

SOURCE Curi Capital

Ce financement permettra d’augmenter la production des IMU photoniques non soumises à l’ITAR d’OSCP à Montréal, afin de répondre à la demande croissante en matière de systèmes de navigation fonctionnant même en cas de brouillage du GNSS.

MONTRÉAL, 1er octobre 2026 — OSCPS Motion Sensing Inc., opérant sous le nom d’OSCP, a annoncé aujourd’hui avoir conclu une levée de fonds de série A menée par New Science Ventures, avec la participation d’Emerging Ventures et de 2050 Capital. Somu Subramaniam, fondateur et associé gérant de New Science Ventures, a rejoint le conseil d’administration d’OSCP.

Les gyroscopes photoniques et les unités de mesure inertielle (IMU) d’OSCP sont conçus pour les plateformes qui doivent continuer à naviguer lorsque le GNSS est brouillé, falsifié ou indisponible, un problème qui dépasse désormais largement les zones de conflit déclarées.

L’entreprise utilisera ces fonds pour développer sa production à Montréal, renforcer ses équipes d’ingénierie et de vente, et commercialiser sa nouvelle génération de capteurs inertiels photoniques.

« La perte du signal satellite était autrefois un problème sur le champ de bataille. On le voit désormais au-dessus des aéroports et des voies maritimes », a déclaré Kazem Zandi, fondateur et directeur général d’OSCP. « Les clients veulent un système de navigation fiable même en cas de perte de signal GNSS et qu’il soit conforme à l’ITAR. Cette phase nous permet d’en construire davantage ici, et plus rapidement. »

« Nous sommes ravis de rejoindre l’équipe d’OSCP pour développer les meilleures unités de mesure inerte (IMU) au monde en termes de performances de navigation, de taille et de coût. Ces unités de mesure inertielles (IMU) ont le potentiel de bouleverser complètement le paradigme de la navigation autonome dans un large éventail d’applications des secteurs de la défense et des transports », a déclaré Somu Subramaniam, fondateur et associé gérant de New Science Ventures.

Depuis la clôture de la levée de fonds en août, OSCP a lancé NavigationGate, un système de navigation inertielle destiné aux plateformes qui perdent le signal satellite, a ajouté la prise en charge d’ArduPilot ainsi qu’un pilote ROS 2 open source pour sa gamme d’IMU MK2, et a été agréé en tant que fournisseur sur la plateforme « Defence Drone Initiative Marketplace » du gouvernement canadien. Pour plus d’informations, rendez-vous sur oscp.com.

À PROPOS D’OSCP

OSCPS Motion Sensing Inc., opérant sous le nom d’OSCP, conçoit et fabrique des gyroscopes photoniques et des unités de mesure inertielle. Fondée en 2015 et basée à Montréal, au Québec, l’entreprise développe des capteurs inertiels offrant une précision photonique de niveau tactique, tout en conservant les caractéristiques des MEMS en termes de taille, de poids, de consommation d’énergie et de coût, pour la navigation dans les zones où le GNSS est brouillé, perturbé ou indisponible. Ses clients sont actifs dans les secteurs de l’espace, de la défense, de la marine et des activités sous-marines, du ferroviaire, de la robotique et de l’autonomie terrestre. Les produits d’OSCP sont fabriqués au Canada et ne sont pas soumis à la réglementation ITAR.

À PROPOS DE NEW SCIENCE VENTURES

New Science Ventures est une société de capital-risque qui investit dans des entreprises adoptant des approches scientifiques novatrices dans les domaines des technologies de l’information et des sciences de la vie. Fondée en 2004 et disposant de bureaux à Greenwich, dans le Connecticut, et à Londres, la société gère plus d’un milliard de dollars américains d’actifs, sur la base des capitaux initialement engagés. Pour plus d’informations, rendez-vous sur newscienceventures.com.

Relations avec les médias : [email protected]

Fortune 1000 companies turn to OptimizeGEO as a unified platform for brand discovery, media, advertising and commerce in an AI era

NEW YORK, Oct. 1, 2026 — OptimizeGEO, the generative engine optimization (GEO) agentic platform that helps multinational brands measure, manage and improve media and commerce across major AI platforms, today announced it counts more than top 100 global brands as clients across 20 countries. As Fortune 1000 companies increasingly prioritize AI-led discovery, Michael Kassan, founder and CEO of 3C Ventures, joins OptimizeGEO as an investor and strategic advisor as the company is accelerating to its next phase of global growth.

Nearly 75% of shoppers use AI for search, discovery, and recommendations. Brands across verticals such as CPG, beauty, financial services, retail, and more, are turning to OptimizeGEO to help them show up where it matters in AI answers. The platform helps enterprise brands and innovative startups optimize their online presence so that AI models and agents understand a brand accurately, cite it credibly and recommend it in the moments that shape consideration and choice.

OptimizeGEO helps global brands capitalize on the new reality of the modern marketing funnel. The platform analyzes visibility, share of voice, sentiment and citations across all major LLMs such as ChatGPT, Claude, Google AI, Perplexity, Gemini and Copilot. The platform’s inherently multilingual capabilities are increasingly important since more than half of active ChatGPT users now predominantly use a language other than English. 

Unlike other GEO platforms that stop at measurement, OptimizeGEO identifies exactly where a brand is gaining or losing influence amongst target consumer personas, prioritizes the opportunities with the greatest commercial potential and recommends what to do next across the marketing mix. Most importantly, the end-to-end platform helps implement recommended actions across technical updates, owned content, earned media placements, creator and retailer strategies as well as paid media via autonomous agents. It then connects those improvements to measurable business growth metrics – qualified traffic, conversions, pipeline and revenue.

OptimizeGEO has helped Glance, a pioneer in AI agentic commerce that works with leading retail and fashion brands with millions of users worldwide, increase AI visibility by 2.5X and share of voice in the AI shopping category by 6.6X from April to July 2026.

Naveen Tewari, Founder and CEO of Glance, said, “More and more, people discover products through AI assistants, not search bars. OptimizeGEO has been a valuable partner in helping us show up in that new discovery layer and turn it into measurable growth. Their insights and execution agents help us spot new opportunities and act on them quickly as we build Glance into an AI personal shopper for everyone.”

The company was co-founded by Kirthiga Reddy, the first employee and MD of Facebook India and an Adweek AI Power 50 2026 winner, and Saurabh Doshi, former Meta APAC MD. Having built their careers during the shift to mobile and social discovery, Reddy and Doshi founded OptimizeGEO around the premise that AI will similarly reshape consumer behavior.

Michael Kassan, Founder and CEO of 3C Ventures, is joining the company as an investor and strategic advisor. At OptimizeGEO, he will advise the founders on global go-to-market strategy, enterprise relationships, ecosystem partnerships and the continued development of the Generative Engine Optimization category.

Kassan said, “AI is fundamentally changing how consumers discover, evaluate and ultimately choose brands. For marketers, that creates an entirely new growth discipline. OptimizeGEO is looking beyond visibility to the larger business opportunity: turning AI visibility into measurable growth. Kirthiga, Saurabh and the team have built something with enormous potential, and I’m excited to invest in the company and advise them as they scale globally.”

Reddy and Doshi said, “The rapid adoption of OptimizeGEO and vote of confidence from Michael and our other advisors and investors solidifies our projection that GEO is the biggest marketing opportunity of this era. As we continue to listen closely to the market, innovate rapidly and expand our platform from intelligence to implementation and measurable growth, Kassan has an invaluable instinct for category creation.”

Kassan joins OptimizeGEO’s investor base of prominent global thought-leaders at the forefront of consumer and marketing tech shifts such as Carolyn Everson, senior advisor at Permira who is on the board of Under Armour, Walt Disney, Boston Consulting Group (BCG), Gulshan Verman, Director of Amazon Ads; Mauria Finley, VP of Google Store and Google Fi Wireless; Stacy Brown-Philpot, Founder and Managing Partner at Cherryrock Capital; Kiran Mani, MD – APAC & Japan, OpenAI; and Shiv Singh, CEO of Savvy Matters, co-Founder of AI Trailblazers, author and former CMO of LendingTree.

The company’s blue-chip institutional investors include f7 Ventures, Micron Ventures, Young Capital, Blockchange, Polygon, Better, Shorooq Partners, VC3, Oceans, Neythri Futures Fund, Perot Jain, Impact Venture Capital and FalconX.

To learn more about OptimizeGEO, please visit: https://www.optimizegeo.ai/ or https://www.linkedin.com/company/optimizegeo/.

About OptimizeGEO

OptimizeGEO is the generative engine optimization (GEO) agentic platform that helps multinational brands measure, manage and improve media and commerce across major AI platforms. The end-to-end platform has autonomous agents to implement approved recommendations for prioritized commercial opportunities through human-in-the-loop workflows for technical updates, owned content, earned media placements, creator and retailer strategies as well as paid media. Built natively for multilingual, multi-market brand discovery, OptimizeGEO works with Fortune 1000 companies and innovative startups to connect AI discovery to qualified traffic, conversions, pipeline and revenue. To learn more, visit optimizegeo.ai or follow the company on LinkedIn (https://www.linkedin.com/company/optimizegeo/).

Media Contacts 
Lacy Talton
Evergreen & Oak on behalf of OptimizeGEO
[email protected]
252.467.5220

SOURCE OptimizeGEO

NEW YORK, Oct. 1, 2026 — Biotia, the clinical metagenomics company whose BIOTIA-ID Urine Test identifies the cause of recurrent and complicated urinary tract infections (UTIs) with 97% sensitivity and 99% specificity, today announced an oversubscribed $9 million financing. The test is available to physicians and patients in all 50 states.

The new financing exceeds Biotia’s previously announced Series A and reflects continued confidence in Biotia’s technology and long-term opportunity. The capital will help scale its New York City laboratory, launch additional diagnostics in women’s health, and expand into orthopedic diagnostics.

“This funding enables us to do what matters most: expand advanced diagnostics available for patients suffering from chronic infections who have been failed by standard laboratory methods,” said Niamh O’Hara, PhD, CEO and cofounder of Biotia. “We are using this capital to expand our test menu, pursue reimbursement, and get these tools into the hands of clinicians — so that more patients get better and faster answers. We are grateful to work every day with strong investors, advisors, and partners transforming how infectious diseases are diagnosed and understood.”

Biotia Expands its Board and Advisors 
Alongside its financing momentum, Biotia has added esteemed healthcare leaders to its board of directors and advisors. These additions bring deep expertise across healthcare delivery, diagnostics, biotechnology, public health and healthcare innovation.

Board Members and Advisors Additions:

• Michele Colucci, Esq., a leading healthcare investor and CEO of DigitalDx Ventures, as board chair
• Tim Barry, a healthcare innovator, cofounder of VillageMD and investor for healthcare startups, as a board member
• Clive Fields, MD, cofounder of VillageMD, veteran primary care practitioner, investor and clinical faculty at University of Texas Health Science Center, as a board observer
• Angelish Kumar, MD, chronic UTI specialist, founder of Women’s Urology New York, as a clinical advisor
• Lesley Northrop, PhD, a pioneer in women’s healthcare diagnostics, clinical diagnostic operations specialist, as an advisory board member
• Catherine Balsam-Schwaber, former CEO of Sōlaria Biō and founder of women’s health company Kindra, as an advisory board member focused on commercialization

“Diagnostics are the foundation of better patient care, since you cannot manage what you cannot accurately measure. Biotia’s approach to precision infectious disease testing, especially their work in women’s health, is exactly the kind of innovation that improves outcomes while reducing unnecessary costs in the system. I’m excited to join the board and help Biotia scale,” said Mr. Barry. 

“The esteemed leaders supporting Biotia at this stage are a testament to the importance of what we are building as we work to make clinical metagenomic solutions rapidly accessible for patients,” said Chris Mason, PhD, global director and cofounder of Biotia. “Their experience and perspective will be invaluable to accelerate our next phase of growth, expand our diagnostic applications to new markets, and help more patients.”

Mr. Barry and Dr. Fields, cofounders of VillageMD, joined other investors in this funding, including Convergent Ventures, DigitalDx Ventures, Cloquet Capital Partners, Continuum Health Ventures,  I-Lab Angels, EGB Capital, Leawood Venture Capital, Red Bear Angels, Red Bear Ventures, and others.

To learn more about Biotia, please visit here. For patients, please visit here.

More about Biotia 
Biotia is advancing infectious disease diagnostics for challenging and chronic infections through pathogen genomics and artificial intelligence. As a spinout company of the Jacobs Technion-Cornell Institute at Cornell Tech, Biotia is based in New York City, where it operates a high-complexity, CLIA-certified diagnostic laboratory. Biotia’s partners and collaborators include leading institutions such as Mayo Clinic, Hospital for Special Surgery (HSS), and NASA. Biotia develops cutting-edge diagnostic and software solutions to help patients, providers, and health systems identify and respond to infectious disease threats. Its flagship diagnostic test for recurrent, complicated UTIs, the BIOTIA-ID Urine Test (sensitivity 97% and specificity 99%), is available across all 50 U.S. states. To learn more about Biotia, visit biotia.io.

Media Contact:
+1 (917) 730-1829
[email protected] 

SOURCE Biotia, Inc.